These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 2995695)
21. Minimal risk of transmission of AIDS-associated retrovirus infection by oral-genital contact. Lyman D; Winkelstein W; Ascher M; Levy JA JAMA; 1986 Apr; 255(13):1703. PubMed ID: 3005675 [No Abstract] [Full Text] [Related]
22. Prevalence of antibody to LAV/HTLV-III among homosexual men in Seattle. Collier AC; Barnes RC; Handsfield HH Am J Public Health; 1986 May; 76(5):564-5. PubMed ID: 3008580 [TBL] [Abstract][Full Text] [Related]
23. Prospective study of cytotoxic T lymphocyte responses to influenza and antibodies to human T lymphotropic virus-III in homosexual men. Selective loss of an influenza-specific, human leukocyte antigen-restricted cytotoxic T lymphocyte response in human T lymphotropic virus-III positive individuals with symptoms of acquired immunodeficiency syndrome and in a patient with acquired immunodeficiency syndrome. Shearer GM; Salahuddin SZ; Markham PD; Joseph LJ; Payne SM; Kriebel P; Bernstein DC; Biddison WE; Sarngadharan MG; Gallo RC J Clin Invest; 1985 Oct; 76(4):1699-704. PubMed ID: 2997287 [TBL] [Abstract][Full Text] [Related]
24. Key epidemiologic questions about AIDS and infection with HTLV-III/LAV. Hopkins DR Public Health Rep; 1986; 101(3):234-7. PubMed ID: 3012620 [No Abstract] [Full Text] [Related]
25. The epidemiology and prevention of the acquired immunodeficiency syndrome. Curran JW Ann Intern Med; 1985 Nov; 103(5):657-62. PubMed ID: 2996395 [TBL] [Abstract][Full Text] [Related]
26. Human T-lymphotropic virus type III in high-risk, antibody-negative homosexual men. Mayer KH; Stoddard AM; McCusker J; Ayotte D; Ferriani R; Groopman JE Ann Intern Med; 1986 Feb; 104(2):194-6. PubMed ID: 3004277 [TBL] [Abstract][Full Text] [Related]
27. HTLV-III/LAV-seronegative, virus-negative sexual partners and household contacts of hemophiliacs. McFadden T; Jason JM; Feorino P JAMA; 1986 Apr; 255(13):1702. PubMed ID: 3005673 [No Abstract] [Full Text] [Related]
28. [AIDS in Africa]. Sansone R; Carobbi S; Alloro G; Strigini P Ann Ig; 1989; 1(5):1057-66. PubMed ID: 2483891 [TBL] [Abstract][Full Text] [Related]
29. HTLV-3 infection and AIDS: risk of spread by heterosexual contact. Craske J IPPF Med Bull; 1986 Feb; 20(1):3-4. PubMed ID: 12267664 [TBL] [Abstract][Full Text] [Related]
30. Seroepidemiological studies of HTLV-III antibody prevalence among selected groups of heterosexual Africans. Clumeck N; Robert-Guroff M; Van de Perre P; Jennings A; Sibomana J; Demol P; Cran S; Gallo RC JAMA; 1985 Nov; 254(18):2599-602. PubMed ID: 2997491 [TBL] [Abstract][Full Text] [Related]
31. HTLV-III AIDS link. Bennett JA Am J Nurs; 1985 Oct; 85(10):1086-9. PubMed ID: 2996353 [TBL] [Abstract][Full Text] [Related]
32. A pathogenic retrovirus (HTLV-III) linked to AIDS. Broder S; Gallo RC N Engl J Med; 1984 Nov; 311(20):1292-7. PubMed ID: 6208484 [TBL] [Abstract][Full Text] [Related]
33. Prevalence of antibody to HTLV-III/LAV in a population attending a sexually transmitted diseases clinic. Rabkin CS; Thomas PA; Jaffe HW; Schultz S Sex Transm Dis; 1987; 14(1):48-51. PubMed ID: 3645806 [TBL] [Abstract][Full Text] [Related]
34. Type-I and type-III HTLV antibodies in hospitalized and out-patient Zairians. Gazzolo L; Robert-Guroff M; Jennings A; Duc Dodon M; Najberg G; Peti MM; de-Thé G Int J Cancer; 1985 Sep; 36(3):373-8. PubMed ID: 2993173 [TBL] [Abstract][Full Text] [Related]
35. Epidemiology of human T-lymphotropic virus type III and the risk of the acquired immunodeficiency syndrome. Blattner WA; Biggar RJ; Weiss SH; Melbye M; Goedert JJ Ann Intern Med; 1985 Nov; 103(5):665-70. PubMed ID: 2996397 [TBL] [Abstract][Full Text] [Related]
36. Human T-lymphotropic virus type III infection in previously immunocompromised hosts. Groopman JE; Hammer SM; Sallan SE; Allan JD J Clin Oncol; 1986 Apr; 4(4):540-3. PubMed ID: 3007685 [TBL] [Abstract][Full Text] [Related]
37. Transmission of lymphadenopathy-associated virus/human T lymphotropic virus type III in sexual partners. Seropositivity does not predict infectivity in all cases. Burger H; Weiser B; Robinson WS; Lifson J; Engleman E; Rouzioux C; Brun-Vézinet F; Barré-Sinoussi F; Montagnier L; Chermann JC Am J Med; 1986 Jul; 81(1):5-10. PubMed ID: 3014878 [TBL] [Abstract][Full Text] [Related]
38. The Vancouver Lymphadenopathy-AIDS Study: 2. Seroepidemiology of HTLV-III antibody. Jeffries E; Willoughby B; Boyko WJ; Schechter MT; Wiggs B; Fay S; O'Shaughnessy M Can Med Assoc J; 1985 Jun; 132(12):1373-7. PubMed ID: 2988729 [TBL] [Abstract][Full Text] [Related]
39. Virologic studies of HTLV-III/LAV in pregnancy: case report of a woman with AIDS. Rogers MF; Ewing EP; Warfield D; Hardy AM; Emery DR; Wolf GC Obstet Gynecol; 1986 Sep; 68(3 Suppl):2S-6S. PubMed ID: 3016628 [TBL] [Abstract][Full Text] [Related]
40. Recommendations for assisting in the prevention of perinatal transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus and acquired immunodeficiency syndrome. Centers for Disease Control (CDC) MMWR Morb Mortal Wkly Rep; 1985 Dec; 34(48):721-6, 731-2. PubMed ID: 2999576 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]